Direct providership by American Academy of Addiction Psychiatry
Sandra A. Springer, MD | Associate Professor of Medicine, Department of Internal Medicine, Section of Infectious Disease, Yale School of Medicine
NOTE: This module has been updated and is being re-released with new information and sources. The module also includes an audio option with Dr. Springer’s recording of her presentation.
This presentation provides an overview of the epidemiology of Hepatitis A, B and C infection among persons who use drugs in the United States as well as an overview of current recommendations on diagnosis and treatment for these infections.
At the conclusion of this activity participants should be able to:
- Understand the importance of HCV and HBV screening among persons who use drugs.
- Understand the treatment options for HCV and HBV infected persons who use drugs.
- Be aware of special issues related to treatment of HCV and HBV in those co-infected with HIV.
American Academy of Addiction Psychiatry (AAAP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credits for completing this activity.
Method of participation in the learning process
In order to receive a maximum of 1 AMA PRA Category 1 Credit™, participants must participate in the entire module, answer post-test questions, pass with a 70% pass rate and complete an evaluation at the end of the activity.